Bicara Therapeutics Inc (NASDAQ:BCAX) has seen 0.18 million shares traded in the last trading session. The company, currently valued at $733.58M, closed the last trade at $13.48 per share which meant it gained $0.36 on the day or 2.74% during that session. The BCAX stock price is -108.38% off its 52-week high price of $28.09 and 17.66% above the 52-week low of $11.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.25 million shares traded. The 3-month trading volume is 431.53K shares.

Bicara Therapeutics Inc (NASDAQ:BCAX) trade information

Sporting 2.74% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BCAX stock price touched $13.48 or saw a rise of 3.37%. Year-to-date, Bicara Therapeutics Inc shares have moved -22.62%, while the 5-day performance has seen it change 11.13%. Over the past 30 days, the shares of Bicara Therapeutics Inc (NASDAQ:BCAX) have changed 4.33%. Short interest in the company has seen 4.08 million shares shorted with days to cover at 10.31.

Wall Street analysts have a consensus price target for the stock at $35, which means that the shares’ value could jump 61.49% from current levels. The projected low price target is $35.0 while the price target rests at a high of $35.0. In that case, then, we find that the current price level is -159.64% off the targeted high while a plunge would see the stock gain -159.64% from current levels.

BCAX Dividends

Bicara Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Bicara Therapeutics Inc (NASDAQ:BCAX)’s Major holders

Also the top two Mutual Funds that are holding company’s shares are Price (T.Rowe) New Horizons Fund and AB Cap Fd.-AB Small Cap Growth Port. As of Sep 30, 2024 , the former fund manager holds about 1.08% shares in the company for having 589.53 shares of worth $7.95 million while later fund manager owns 400.96 shares of worth $5.4 million as of Dec 31, 2024 , which makes it owner of about 0.74% of company’s outstanding stock.